{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:43:29Z","timestamp":1789177409658,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership (EDCTP)","doi-asserted-by":"crossref","award":["CB.07.41700.006"],"award-info":[{"award-number":["CB.07.41700.006"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Drug Resistance and Containment, Global Malaria Programme, World Health Organization, Geneva, Switzerland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0918-6","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T02:56:31Z","timestamp":1446087391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10\u00a0years old living in a suburban area: a randomized study"],"prefix":"10.1186","volume":"14","author":[{"given":"Mathieu","family":"Ndounga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pembe Issamou Mayengue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisca Nadine","family":"Casimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Koukouikila-Koussounda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bitemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunelle","family":"Diassivy Matondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Aymar","family":"Ndounga Diakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo K.","family":"Basco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Ntoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"918_CR1","first-page":"5","volume":"56","author":"JR Mabiala-Babela","year":"2009","unstructured":"Mabiala-Babela JR, Makoumbou PB, Mbika Cardorelle A, Tsiba JB, Senga P. Evolution de la mortalit\u00e9 hospitali\u00e8re chez l\u2019enfant \u00e0 Brazzaville. Med Afr Noire. 2009;56:5\u20138.","journal-title":"Med Afr Noire"},{"issue":"40","key":"918_CR2","first-page":"177","volume":"1993","author":"G Moyen","year":"1073","unstructured":"Moyen G, Nzingoula S, Mowandza-Ndinga JC, Nkoua JL, Mpemba AB, Fourcarde V. Le paludisme de l\u2019enfant dans un service de p\u00e9diatrie \u00e0 Brazzaville. A propos de 1073 observations. M\u00e9d Afr Noire. 1073;1993(40):177\u201381.","journal-title":"M\u00e9d Afr Noire"},{"key":"918_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3185\/pathexo3111","volume":"101","author":"M Ndounga","year":"2008","unstructured":"Ndounga M, Casimiro PN, Miakassissa-Mpassi V, Loumouamou D, Ntoumi F, Basco LK. Malaria in health centres in the southern districts of Brazzaville, Congo. Bull Soc Pathol Exot. 2008;101:329\u201335.","journal-title":"Bull Soc Pathol Exot."},{"key":"918_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.actatropica.2005.06.001","volume":"95","author":"PI Mayengue","year":"2005","unstructured":"Mayengue PI, Ndounga M, Matondo Maya D, Ntandou N, Ntoumi F. In vivo chloroquine resistance of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Congo. Acta Trop. 2005;95:219\u201325.","journal-title":"Acta Trop."},{"key":"918_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.actatropica.2007.06.002","volume":"103","author":"M Ndounga","year":"2007","unstructured":"Ndounga M, Mayengue PI, Tahar R, Casimiro PN, Matondo Maya DW, Miakassissa-Mpassi V, et al. Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo). Acta Trop. 2007;103:163\u201371.","journal-title":"Acta Trop"},{"key":"918_CR6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-3156.2005.01490.x","volume":"10","author":"B Nsimba","year":"2005","unstructured":"Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, et al. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use. Trop Med Int Health. 2005;10:1030\u20137.","journal-title":"Trop Med Int Health."},{"key":"918_CR7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-3156.2007.01904.x","volume":"12","author":"M Ndounga","year":"2007","unstructured":"Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo. Trop Med Int Health. 2007;12:1164\u201371.","journal-title":"Trop Med Int Health."},{"key":"918_CR8","first-page":"34","volume":"35","author":"M Ndounga","year":"2002","unstructured":"Ndounga M, Ebata-Mongo S, Mallandah G, Bassouamina L, Issoibeka R, Basco L. Fi\u00e8vres et prise en charge du paludisme dans les centres de sant\u00e9 int\u00e9gr\u00e9 de Brazzaville (Congo). Bulletin de Liaison et de Documentation de l\u2019OCEAC. 2002;35:34\u201342.","journal-title":"Bulletin de Liaison et de Documentation de l\u2019OCEAC"},{"key":"918_CR9","volume-title":"Antimalarial drug combination therapy. Report of a WHO technical consultation","author":"WHO","year":"2001","unstructured":"WHO. Antimalarial drug combination therapy. Report of a WHO technical consultation. Geneva: World Health Organization; 2001."},{"key":"918_CR10","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2006","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2006."},{"key":"918_CR11","volume-title":"The African malaria report","author":"WHO","year":"2006","unstructured":"WHO. The African malaria report. Geneva: World Health Organization; 2006."},{"key":"918_CR12","volume-title":"World Health Report 2012","author":"WHO","year":"2012","unstructured":"WHO. World Health Report 2012. Geneva: World Health Organization; 2012."},{"key":"918_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1475-2875-9-240","volume":"9","author":"V D\u2019Acremont","year":"2010","unstructured":"D\u2019Acremont V, Lengeler C, Genton B. Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar J. 2010;9:240. doi: 10.1186\/1475-2875-9-240 .","journal-title":"Malar J."},{"key":"918_CR14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(10)70096-7","volume":"10","author":"WP O\u2019Meara","year":"2010","unstructured":"O\u2019Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10:545\u201355.","journal-title":"Lancet Infect Dis."},{"key":"918_CR15","volume-title":"R\u00e9publique du Congo: Politique nationale de lutte contre le paludisme","author":"Minist\u00e8re de la Sant\u00e9 et de la Population","year":"2006","unstructured":"Minist\u00e8re de la Sant\u00e9 et de la Population. R\u00e9publique du Congo: Politique nationale de lutte contre le paludisme. Brazzaville: Ministry of Health and Population; 2006."},{"key":"918_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1475-2875-5-113","volume":"5","author":"I Broek van den","year":"2006","unstructured":"van den Broek I, Kitz C, Al Attas S, Libama F, Balasegaram M, Guthmann JP. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Malar J. 2006;5:113.","journal-title":"Malar J"},{"key":"918_CR17","first-page":"749479","volume":"2012","author":"M Ndounga","year":"2012","unstructured":"Ndounga M, Tahar R, Casimiro PN, Loumouamou D, Basco LK. Clinical efficacy of artemether-lumefantrine in Congolese children with acute uncomplicated falciparum malaria in Brazzaville. Malar Res Treat. 2012;2012:749479. doi: 10.1155\/2012\/749479 .","journal-title":"Malar Res Treat."},{"key":"918_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2875-12-53","volume":"12","author":"M Ndounga","year":"2013","unstructured":"Ndounga M, Mayengue PI, Casimiro PN, Loumouamou D, Basco LK, Ntoumi F, et al. Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville. Malar J. 2013;12:53.","journal-title":"Malar J"},{"key":"918_CR19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00034989859429","volume":"92","author":"NJ White","year":"1998","unstructured":"White NJ. Why is it that antimalarial drug treatments do not always work. Ann Trop Med Parasitol. 1998;92:449\u201358.","journal-title":"Ann Trop Med Parasitol"},{"key":"918_CR20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/345363","volume":"186","author":"DJ Terlouw","year":"2002","unstructured":"Terlouw DJ, Aidoo MA, Udhayakumar V, Kolczak MS, Oloo AJ, Kager PA, et al. Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya. J Infect Dis. 2002;186:1661\u20138.","journal-title":"J Infect Dis"},{"key":"918_CR21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1172\/JCI113910","volume":"83","author":"Y Yuthavong","year":"1989","unstructured":"Yuthavong Y, Butthep P, Bunyaratvej A, Fucharoen S. Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and\/or hemoglobin constant spring erythrocytes. J Clin Invest. 1989;83:502\u20135.","journal-title":"J Clin Invest."},{"key":"918_CR22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0035-9203(97)90037-7","volume":"91","author":"AC Senok","year":"1997","unstructured":"Senok AC, Nelson EAS, Li K, Oppenheimer SJ. Thalassaemia trait, red blood cell age and oxidant stress: effects on growth and sensitivity to artemisinin. Trans R Soc Trop Med Hyg. 1997;91:585\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"918_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1365-3156.2001.00688.x","volume":"6","author":"FP Mockenhaupt","year":"2001","unstructured":"Mockenhaupt FP, May J, Bergqvist Y, Meyer CG, Falusi AG, Bienzle U. Evidence for a reduced effect of chloroquine against Plasmodium falciparum in alpha-thalassaemic children. Trop Med Int Health. 2001;6:102\u20137.","journal-title":"Trop Med Int Health"},{"issue":"Suppl 2","key":"918_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0035-9203(87)90472-X","volume":"81","author":"JF Trape","year":"1987","unstructured":"Trape JF, Zoulani A. Malaria and urbanization in central Africa: the example of Brazzaville. Part II: Results of entomological surveys and epidemiological analysis. Trans R Soc Trop Med Hyg. 1987;81(Suppl 2):10\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"918_CR25","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009."},{"key":"918_CR26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/JCM.29.6.1171-1174.1991","volume":"29","author":"KC Kain","year":"1991","unstructured":"Kain KC, Lanar DE. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J Clin Microbiol. 1991;29:1171\u20134.","journal-title":"J Clin Microbiol"},{"key":"918_CR27","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations","author":"WHO","year":"2008","unstructured":"WHO. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization; 2008."},{"key":"918_CR28","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1073\/pnas.86.8.2757","volume":"86","author":"DY Wu","year":"1989","unstructured":"Wu DY, Ugozzoli L, Pal BK, Wallace RB. Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci USA. 1989;86:2757\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"918_CR29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.exppara.2005.09.014","volume":"112","author":"DW Matondo Maya","year":"2006","unstructured":"Matondo Maya DW, Mavoungou E, Deloron P, Theisen M, Ntoumi F. Distribution of IgG subclass antibodies specific for Plasmodium falciparum glutamate-rich-protein molecule in sickle cell trait children with asymptomatic infections. Exp Parasitol. 2006;112:92\u20138.","journal-title":"Exp Parasitol."},{"key":"918_CR30","volume-title":"World malaria report 2008","author":"WHO","year":"2008","unstructured":"WHO. World malaria report 2008. Geneva: World Health Organization; 2008."},{"key":"918_CR31","unstructured":"Minist\u00e8re de la sant\u00e9 et de la Population. Politique nationale de lutte contre le paludisme. R\u00e9publique du Congo; 2014."},{"key":"918_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-13-9","volume":"13","author":"D Djall\u00e9","year":"2014","unstructured":"Djall\u00e9 D, Njuimo SP, Manirakiza A, Laganier R, Le Faou A, Rogier C. Efficacy and safety of artemether\u00a0+\u00a0lumefantrine, artesunate\u00a0+\u00a0sulphamethoxypyrazine-pyrimethamine and artesunate\u00a0+\u00a0amodiaquine and sulphadoxine-pyrimethamine\u00a0+\u00a0amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Malar J. 2014;13:9. doi: 10.1186\/1475-2875-13-9 .","journal-title":"Malar J."},{"key":"918_CR33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-3156.2004.01255.x","volume":"9","author":"A Ndayiragije","year":"2004","unstructured":"Ndayiragije A, Niyungeko D, Karenzo J, Niyungeko E, Barutwanayo M, Ciza A, et al. Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi. Trop Med Int Health. 2004;9:673\u20139.","journal-title":"Trop Med Int Health"},{"key":"918_CR34","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1128\/AAC.02682-14","volume":"58","author":"MA Onyamboko","year":"2014","unstructured":"Onyamboko MA, Fanello CI, Wongsaen K, Tarning J, Cheah PY, Tshefu KA, et al. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo. Antimicrob Agents Chemother. 2014;58:5528\u201336. doi: 10.1128\/AAC.02682-14 .","journal-title":"Antimicrob Agents Chemother"},{"key":"918_CR35","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10:e1001484. doi: 10.1371\/journal.pmed.1001484 .","journal-title":"PLoS Med."},{"key":"918_CR36","first-page":"447","volume":"70","author":"B Ngasia","year":"2010","unstructured":"Ngasia B. Proceedings of the first symposium on sickle cell disease in Central Africa. Med Trop (Mars). 2010;70:447\u20138.","journal-title":"Med Trop (Mars)."},{"key":"918_CR37","volume-title":"World Malaria report 2014","author":"WHO","year":"2014","unstructured":"WHO. World Malaria report 2014. Geneva: World Health Organization; 2014."},{"key":"918_CR38","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(02)08273-9","volume":"359","author":"M Aidoo","year":"2002","unstructured":"Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359:1311\u20132.","journal-title":"Lancet"},{"key":"918_CR39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mib.2006.06.009","volume":"9","author":"TN Williams","year":"2006","unstructured":"Williams TN. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol. 2006;9:388\u201394.","journal-title":"Curr Opin Microbiol"},{"key":"918_CR40","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.4081\/hr.2011.e24","volume":"3","author":"S Eridani","year":"2011","unstructured":"Eridani S. Sickle cell protection from malaria. Hematol Rep. 2011;3:e24. doi: 10.4081\/hr.2011.e24 .","journal-title":"Hematol Rep."},{"key":"918_CR41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cell.2011.03.049","volume":"145","author":"A Ferreira","year":"2011","unstructured":"Ferreira A, Marguti I, Bechmann I, Jeney V, Chora A, Palha NR, Rebelo S, Henri A, Beuzard Y, Soares MP. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell. 2011;145:398\u2013409. doi: 10.1016\/j.cell.2011.03.049 .","journal-title":"Cell"},{"key":"918_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1475-2875-8-237","volume":"8","author":"V Nakibuuka","year":"2009","unstructured":"Nakibuuka V, Ndeezi G, Nakiboneka D, Ndugwa CM, Tumwine JK. Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial. Malar J. 2009;8:237. doi: 10.1186\/1475-2875-8-237 .","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0918-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T14:12:41Z","timestamp":1599747161000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0918-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"article-number":"423"}}